近日,白云山公告(600332.SH)拟作为有限合伙人以斥资近15亿元参与设立广州广药基金二期股权投资合伙企业(有限合伙)(简称“广药基金二期”),后者通过直接或间接的方式开展生物医药领域的股权投资。白云山此举意在加速布局生物医药健康产业。证券之星注意到,作为老牌药企,白云山正深陷“2024年归母净利同比下滑三成,创2017年以来新低”的业绩困局。这背后是明星产品“金戈”销售滑坡、王老吉凉茶式微及...
Source Link近日,白云山公告(600332.SH)拟作为有限合伙人以斥资近15亿元参与设立广州广药基金二期股权投资合伙企业(有限合伙)(简称“广药基金二期”),后者通过直接或间接的方式开展生物医药领域的股权投资。白云山此举意在加速布局生物医药健康产业。证券之星注意到,作为老牌药企,白云山正深陷“2024年归母净利同比下滑三成,创2017年以来新低”的业绩困局。这背后是明星产品“金戈”销售滑坡、王老吉凉茶式微及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.